SG11202001131TA - Amino acid compositions for the treatment of neuronal injury - Google Patents
Amino acid compositions for the treatment of neuronal injuryInfo
- Publication number
- SG11202001131TA SG11202001131TA SG11202001131TA SG11202001131TA SG11202001131TA SG 11202001131T A SG11202001131T A SG 11202001131TA SG 11202001131T A SG11202001131T A SG 11202001131TA SG 11202001131T A SG11202001131T A SG 11202001131TA SG 11202001131T A SG11202001131T A SG 11202001131TA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- amino acid
- acid compositions
- neuronal injury
- neuronal
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 208000014674 injury Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0626—Isoleucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0628—Leucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0634—N-Acetyl-Cysteine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0654—Valine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/306—Creatine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762545364P | 2017-08-14 | 2017-08-14 | |
US201862614198P | 2018-01-05 | 2018-01-05 | |
US201862697690P | 2018-07-13 | 2018-07-13 | |
PCT/US2018/046659 WO2019036442A1 (fr) | 2017-08-14 | 2018-08-14 | Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronale |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202001131TA true SG11202001131TA (en) | 2020-03-30 |
Family
ID=63449701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202001131TA SG11202001131TA (en) | 2017-08-14 | 2018-08-14 | Amino acid compositions for the treatment of neuronal injury |
Country Status (18)
Country | Link |
---|---|
US (1) | US20190046486A1 (fr) |
EP (1) | EP3684350A1 (fr) |
JP (2) | JP7370960B2 (fr) |
KR (1) | KR20200040276A (fr) |
CN (1) | CN111295186A (fr) |
AU (1) | AU2018318091A1 (fr) |
BR (1) | BR112020002244A2 (fr) |
CA (1) | CA3072092A1 (fr) |
CL (1) | CL2020000383A1 (fr) |
CO (1) | CO2020001627A2 (fr) |
IL (1) | IL272336A (fr) |
JO (1) | JOP20200035A1 (fr) |
MA (1) | MA50155A (fr) |
MX (1) | MX2020001766A (fr) |
PE (1) | PE20200748A1 (fr) |
SG (1) | SG11202001131TA (fr) |
TW (1) | TW201919602A (fr) |
WO (1) | WO2019036442A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
WO2018201024A1 (fr) | 2017-04-28 | 2018-11-01 | Axcella Health Inc. | Compositions d'acides aminés et leur utilisation pour le traitement d'une lésion cérébrale traumatique |
PE20200747A1 (es) | 2017-08-14 | 2020-07-24 | Axcella Health Inc | Composiciones de aminoacidos para el tratamiento de enfermedad hepatica |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
AR115581A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Métodos de preparación de composiciones de aminoácidos |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
WO2022029785A1 (fr) * | 2020-08-06 | 2022-02-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Oléylcystéinamide ou dérivés de celui-ci et leurs utilisations en thérapie |
US20220218640A1 (en) * | 2021-01-14 | 2022-07-14 | Rob Dickerman | Amino acid delivery system |
US11931127B1 (en) * | 2021-04-08 | 2024-03-19 | T-Mobile Usa, Inc. | Monitoring users biological indicators using a 5G telecommunication network |
TW202315605A (zh) | 2021-07-26 | 2023-04-16 | 美商胺細拉健康公司 | 用於治療covid—19急性後期後遺症的胺基酸組合物及方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438144A (en) * | 1980-07-31 | 1984-03-20 | Blackburn George L | Amino acid preparation and therapy for treatment of stress and injury |
US20050107338A1 (en) * | 2003-11-17 | 2005-05-19 | Seidman Michael D. | Nutritional supplement enhancing mitochondrial function |
JP5290744B2 (ja) * | 2005-03-21 | 2013-09-18 | アボット・ラボラトリーズ | 糖耐性を改善するためのアミノ酸組成物 |
CN101693740B (zh) * | 2009-10-16 | 2011-09-07 | 中国人民解放军第四军医大学 | Homer1蛋白及其在治疗或预防脑损伤疾病中的应用 |
EP2670403B1 (fr) * | 2011-02-04 | 2021-08-18 | Hough Ear Institute | Méthodes de traitement de lésions cérébrales |
WO2012125020A1 (fr) * | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Méthode de traitement d'un traumatisme neurologique |
US20130090356A1 (en) * | 2011-06-24 | 2013-04-11 | Jon D. Kaiser | Compositions and methods for treatment of neuropsychological deficits |
CA2799127C (fr) * | 2012-12-18 | 2021-05-18 | Matthew Bennett | Compositions et methodes pour traiter une lesion cerebrale traumatique |
US20160058726A1 (en) * | 2013-04-16 | 2016-03-03 | The Children's Hospital Of Philadelphia | Compositions and methods for the treatment of brain injury |
CN106361738A (zh) * | 2016-08-25 | 2017-02-01 | 南通大学 | 治疗、预防脑白质损伤的医药组合物及其医药用途 |
US20180133185A1 (en) * | 2016-11-11 | 2018-05-17 | The Children's Hospital Of Philadelphia | Compositions and Methods for the Improvement of Memory |
JOP20190147A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات |
JOP20190146A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
-
2018
- 2018-08-14 KR KR1020207007011A patent/KR20200040276A/ko not_active Application Discontinuation
- 2018-08-14 EP EP18762716.1A patent/EP3684350A1/fr active Pending
- 2018-08-14 WO PCT/US2018/046659 patent/WO2019036442A1/fr unknown
- 2018-08-14 JO JOP/2020/0035A patent/JOP20200035A1/ar unknown
- 2018-08-14 CA CA3072092A patent/CA3072092A1/fr not_active Abandoned
- 2018-08-14 MX MX2020001766A patent/MX2020001766A/es unknown
- 2018-08-14 MA MA050155A patent/MA50155A/fr unknown
- 2018-08-14 US US16/103,200 patent/US20190046486A1/en not_active Abandoned
- 2018-08-14 AU AU2018318091A patent/AU2018318091A1/en not_active Abandoned
- 2018-08-14 BR BR112020002244-6A patent/BR112020002244A2/pt not_active Application Discontinuation
- 2018-08-14 PE PE2020000251A patent/PE20200748A1/es unknown
- 2018-08-14 CN CN201880065642.6A patent/CN111295186A/zh active Pending
- 2018-08-14 SG SG11202001131TA patent/SG11202001131TA/en unknown
- 2018-08-14 TW TW107128277A patent/TW201919602A/zh unknown
- 2018-08-14 JP JP2020507989A patent/JP7370960B2/ja active Active
-
2020
- 2020-01-29 IL IL272336A patent/IL272336A/en unknown
- 2020-02-13 CO CONC2020/0001627A patent/CO2020001627A2/es unknown
- 2020-02-14 CL CL2020000383A patent/CL2020000383A1/es unknown
-
2023
- 2023-07-07 JP JP2023112589A patent/JP2023145496A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2018318091A1 (en) | 2020-02-13 |
WO2019036442A9 (fr) | 2020-02-13 |
JOP20200035A1 (ar) | 2020-02-13 |
MX2020001766A (es) | 2020-07-29 |
TW201919602A (zh) | 2019-06-01 |
JP7370960B2 (ja) | 2023-10-30 |
PE20200748A1 (es) | 2020-07-24 |
US20190046486A1 (en) | 2019-02-14 |
EP3684350A1 (fr) | 2020-07-29 |
JP2023145496A (ja) | 2023-10-11 |
JP2020530843A (ja) | 2020-10-29 |
CO2020001627A2 (es) | 2020-06-09 |
IL272336A (en) | 2020-03-31 |
KR20200040276A (ko) | 2020-04-17 |
WO2019036442A1 (fr) | 2019-02-21 |
MA50155A (fr) | 2020-07-29 |
BR112020002244A2 (pt) | 2020-08-04 |
CA3072092A1 (fr) | 2019-02-21 |
CL2020000383A1 (es) | 2020-08-28 |
AU2018318091A8 (en) | 2020-03-12 |
CN111295186A (zh) | 2020-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272336A (en) | Amino acid compounds for the treatment of nerve damage | |
IL284371B (en) | Amino acid compounds and methods for treating liver diseases | |
IL298689B1 (en) | Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions | |
IL267210A (en) | Amino acid compounds and methods for treating muscle diseases and disorders | |
SG11201801024XA (en) | Therapeutic or preventive compositions for il-8-related diseases | |
IL286592A (en) | Amino acid compounds for the treatment of liver disease | |
IL260352B (en) | Methods and preparations for the treatment of neurological disease | |
HK1256721A1 (zh) | 用於治療眼部病症的化合物和組合物 | |
IL262348A (en) | Preparations for the treatment of excessive radiation disorders | |
GB202017977D0 (en) | Compositions for the treatment of skin conditions | |
GB202017321D0 (en) | Compositions for the treatment of skin conditions | |
IL272601A (en) | Pharmaceutical preparations for the treatment of ophthalmic conditions | |
PL3348273T3 (pl) | Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych | |
GB201612043D0 (en) | Composition for treatment of disorders | |
IL261779B (en) | Preparations for the treatment and prevention of hoof and claw disease | |
IL256919A (en) | Pharmaceutical compositions useful for the treatment of tissue damage | |
EP3362085C0 (fr) | Compositions pour le traitement de maladies impliquant la mucine | |
ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
GB201901130D0 (en) | Formulation for the treatment of tendinopathies | |
GB201603510D0 (en) | Compositions for use in the treatment of neurological disease |